PT 617 - Alan Davis - Psychedelic Research and Patient Safety at Ohio State & Exploring Ibogaine's Potential

Psychedelics Today

Psychedelics Today, LLC

Life Sciences, Science, Medicine, Health & Fitness

4.6 • 598 Ratings

🗓️ 24 July 2025

⏱️ 75 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this episode of Psychedelics Today, Joe Moore sits down with Alan Davis, Associate Professor at Ohio State University, to explore the evolving landscape of Ibogaine research and its therapeutic potential.

Alan offers a deep dive into the Iboga Patient Survey, a groundbreaking initiative collecting real-world data on the safety and efficacy of Ibogaine—particularly for those struggling with substance use disorders and mental health challenges. The conversation sheds light on the need for rigorous, community-informed research that could pave the way toward FDA approval and increased access for patients, including veterans dealing with trauma.

They also discuss the complexities of clinical trials, the tension between state and federal regulations, and the growing influence of corporate interests in psychedelic research. Alan emphasizes the importance of ethical transparency, community collaboration, and maintaining scientific integrity as the field grows.

If you're curious about the intersection of psychedelic medicine, clinical research, and patient safety, this is a must-listen episode.

Topics Covered

00:00 – Introduction and Guest Welcome
00:53 – Reflecting on COVID-19's Psychological Impact
01:29 – Introducing the Iboga Patient Survey
01:46 – History and Goals of Ibogaine Research
02:41 – Challenges in Conducting Clinical Trials
03:14 – Importance of Real-World Safety Data
06:55 – Personal Interest in Ibogaine
08:56 – Veterans and Trauma: A Personal Connection
10:53 – Reintegration and Emotional Processing
15:29 – Survey Participation and Accessibility
18:25 – Building Partnerships and Overcoming Challenges
21:06 – Ensuring Safety and Transparency
31:49 – Community and Academic Collaboration
33:06 – Survey Design and Future Research Directions
36:50 – Momentum in Psychedelic Research
37:48 – State vs. Federal Regulation
39:23 – Challenges in Psychedelic Treatment
43:01 – Corporate Interests and Scientific Objectivity
47:20 – Ketamine and Collaborative Research
51:56 – Ibogaine Patient Survey
57:55 – Psychedelics and Pain Research
01:07:22 – Conclusion and Future Directions

Transcript

Click on a timestamp to play from that location

0:00.0	Hello, everybody, welcome back to Psychedelics. This is Joe Moore. Today on the show, we have
0:25.6	Alan Davis, PhD, associate professor at Ohio State University and adjunct faculty at John Hopkins.
0:33.2	We talk primarily about a project going on at his center, the Center for Psychedelic Drug Research and Education.
0:41.3	It's kind of an Ibogaine patient survey.
0:44.6	And it's a major effort to gather real data around safety and outcomes on Iboga and Ibogaine.
0:51.0	And I think it's really important because this is a really, I think, going to be an
0:57.0	essential drug in the future. And there's some risks. And we need to figure those out. And we also
1:02.7	want to like get a real, you know, scientific view of what's happening out there. Because a lot
1:08.4	of what we have from the IbBigo iboga world is really
1:11.5	anecdotal and that only goes so far right so we um really like this research um for veterans
1:19.3	people get navigating trauma and those seeking alternative treatments um and this is really cool
1:26.7	because there's a lot of like room for lessons on ethics
1:31.0	and collaboration and transparency. There's a little bit too much secrecy in the Iboga space,
1:35.2	in my opinion. And there's also all sorts of really interesting and problematic IP stuff in the
1:40.9	Ipoga and Ivagane space. So it's going to be a really interesting landscape.
1:44.9	And I think this survey, the Iboca patient survey, is really going to help us understand what we
1:50.3	have ahead of us and how this might look in the future.
1:53.8	So thank you to Alan Davis for joining us.
1:56.5	Thanks to all of you for listening.
1:59.1	And I just want to mention a few things we have coming up and we'll get on with the show.
2:05.1	September 9th, Kyle's teaching a nine-week program called Essentials of Psychedelic Therapy and Integration.
2:12.1	We also have a breathwork retreat coming up in late September, September 26 through 28 in the Colorado Rockies
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Psychedelics Today, LLC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Psychedelics Today, LLC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.